Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma

NCT03469934 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Asthma

Interventions

BIOLOGICAL: Etokimab
DRUG: Placebo

Sponsor

AnaptysBio, Inc.